1 Introduction to Research & Analysis Reports
1.1 Genomic and Proteomic Tool Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genomic and Proteomic Tool Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genomic and Proteomic Tool Overall Market Size
2.1 Global Genomic and Proteomic Tool Market Size: 2022 VS 2029
2.2 Global Genomic and Proteomic Tool Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genomic and Proteomic Tool Players in Global Market
3.2 Top Global Genomic and Proteomic Tool Companies Ranked by Revenue
3.3 Global Genomic and Proteomic Tool Revenue by Companies
3.4 Top 3 and Top 5 Genomic and Proteomic Tool Companies in Global Market, by Revenue in 2022
3.5 Global Companies Genomic and Proteomic Tool Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genomic and Proteomic Tool Players in Global Market
3.6.1 List of Global Tier 1 Genomic and Proteomic Tool Companies
3.6.2 List of Global Tier 2 and Tier 3 Genomic and Proteomic Tool Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Genomic and Proteomic Tool Market Size Markets, 2022 & 2029
4.1.2 Genomics
4.1.3 Proteomics
4.2 By Type – Global Genomic and Proteomic Tool Revenue & Forecasts
4.2.1 By Type – Global Genomic and Proteomic Tool Revenue, 2018-2023
4.2.2 By Type – Global Genomic and Proteomic Tool Revenue, 2024-2029
4.2.3 By Type – Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Genomic and Proteomic Tool Market Size, 2022 & 2029
5.1.2 Research Labs and Institutes
5.1.3 Drug Discovery
5.1.4 Bioinformatics
5.1.5 Others
5.2 By Application – Global Genomic and Proteomic Tool Revenue & Forecasts
5.2.1 By Application – Global Genomic and Proteomic Tool Revenue, 2018-2023
5.2.2 By Application – Global Genomic and Proteomic Tool Revenue, 2024-2029
5.2.3 By Application – Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Genomic and Proteomic Tool Market Size, 2022 & 2029
6.2 By Region – Global Genomic and Proteomic Tool Revenue & Forecasts
6.2.1 By Region – Global Genomic and Proteomic Tool Revenue, 2018-2023
6.2.2 By Region – Global Genomic and Proteomic Tool Revenue, 2024-2029
6.2.3 By Region – Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Genomic and Proteomic Tool Revenue, 2018-2029
6.3.2 US Genomic and Proteomic Tool Market Size, 2018-2029
6.3.3 Canada Genomic and Proteomic Tool Market Size, 2018-2029
6.3.4 Mexico Genomic and Proteomic Tool Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Genomic and Proteomic Tool Revenue, 2018-2029
6.4.2 Germany Genomic and Proteomic Tool Market Size, 2018-2029
6.4.3 France Genomic and Proteomic Tool Market Size, 2018-2029
6.4.4 U.K. Genomic and Proteomic Tool Market Size, 2018-2029
6.4.5 Italy Genomic and Proteomic Tool Market Size, 2018-2029
6.4.6 Russia Genomic and Proteomic Tool Market Size, 2018-2029
6.4.7 Nordic Countries Genomic and Proteomic Tool Market Size, 2018-2029
6.4.8 Benelux Genomic and Proteomic Tool Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Genomic and Proteomic Tool Revenue, 2018-2029
6.5.2 China Genomic and Proteomic Tool Market Size, 2018-2029
6.5.3 Japan Genomic and Proteomic Tool Market Size, 2018-2029
6.5.4 South Korea Genomic and Proteomic Tool Market Size, 2018-2029
6.5.5 Southeast Asia Genomic and Proteomic Tool Market Size, 2018-2029
6.5.6 India Genomic and Proteomic Tool Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Genomic and Proteomic Tool Revenue, 2018-2029
6.6.2 Brazil Genomic and Proteomic Tool Market Size, 2018-2029
6.6.3 Argentina Genomic and Proteomic Tool Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Genomic and Proteomic Tool Revenue, 2018-2029
6.7.2 Turkey Genomic and Proteomic Tool Market Size, 2018-2029
6.7.3 Israel Genomic and Proteomic Tool Market Size, 2018-2029
6.7.4 Saudi Arabia Genomic and Proteomic Tool Market Size, 2018-2029
6.7.5 UAE Genomic and Proteomic Tool Market Size, 2018-2029
7 Genomic and Proteomic Tool Companies Profiles
7.1 3billion, Inc.
7.1.1 3billion, Inc. Company Summary
7.1.2 3billion, Inc. Business Overview
7.1.3 3billion, Inc. Genomic and Proteomic Tool Major Product Offerings
7.1.4 3billion, Inc. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.1.5 3billion, Inc. Key News & Latest Developments
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Bio-Rad Laboratories, Inc. Company Summary
7.2.2 Bio-Rad Laboratories, Inc. Business Overview
7.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Major Product Offerings
7.2.4 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.2.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.3 Lucigen Corp.
7.3.1 Lucigen Corp. Company Summary
7.3.2 Lucigen Corp. Business Overview
7.3.3 Lucigen Corp. Genomic and Proteomic Tool Major Product Offerings
7.3.4 Lucigen Corp. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.3.5 Lucigen Corp. Key News & Latest Developments
7.4 Macrogen, Inc.
7.4.1 Macrogen, Inc. Company Summary
7.4.2 Macrogen, Inc. Business Overview
7.4.3 Macrogen, Inc. Genomic and Proteomic Tool Major Product Offerings
7.4.4 Macrogen, Inc. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.4.5 Macrogen, Inc. Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Genomic and Proteomic Tool Major Product Offerings
7.5.4 Abbott Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 Thermal Fisher Scientific, Inc.
7.6.1 Thermal Fisher Scientific, Inc. Company Summary
7.6.2 Thermal Fisher Scientific, Inc. Business Overview
7.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Major Product Offerings
7.6.4 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.6.5 Thermal Fisher Scientific, Inc. Key News & Latest Developments
7.7 Bio-Synthesis, Inc.
7.7.1 Bio-Synthesis, Inc. Company Summary
7.7.2 Bio-Synthesis, Inc. Business Overview
7.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Major Product Offerings
7.7.4 Bio-Synthesis, Inc. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.7.5 Bio-Synthesis, Inc. Key News & Latest Developments
7.8 GE Healthcare
7.8.1 GE Healthcare Company Summary
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Genomic and Proteomic Tool Major Product Offerings
7.8.4 GE Healthcare Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.8.5 GE Healthcare Key News & Latest Developments
7.9 QIAGEN NV
7.9.1 QIAGEN NV Company Summary
7.9.2 QIAGEN NV Business Overview
7.9.3 QIAGEN NV Genomic and Proteomic Tool Major Product Offerings
7.9.4 QIAGEN NV Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.9.5 QIAGEN NV Key News & Latest Developments
7.10 Novogene Corp.
7.10.1 Novogene Corp. Company Summary
7.10.2 Novogene Corp. Business Overview
7.10.3 Novogene Corp. Genomic and Proteomic Tool Major Product Offerings
7.10.4 Novogene Corp. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.10.5 Novogene Corp. Key News & Latest Developments
7.11 Waters Corp.
7.11.1 Waters Corp. Company Summary
7.11.2 Waters Corp. Business Overview
7.11.3 Waters Corp. Genomic and Proteomic Tool Major Product Offerings
7.11.4 Waters Corp. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.11.5 Waters Corp. Key News & Latest Developments
7.12 OriGene Technologies
7.12.1 OriGene Technologies Company Summary
7.12.2 OriGene Technologies Business Overview
7.12.3 OriGene Technologies Genomic and Proteomic Tool Major Product Offerings
7.12.4 OriGene Technologies Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.12.5 OriGene Technologies Key News & Latest Developments
7.13 Takara Bio, Inc.
7.13.1 Takara Bio, Inc. Company Summary
7.13.2 Takara Bio, Inc. Business Overview
7.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Major Product Offerings
7.13.4 Takara Bio, Inc. Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.13.5 Takara Bio, Inc. Key News & Latest Developments
7.14 Vela Diagnostics
7.14.1 Vela Diagnostics Company Summary
7.14.2 Vela Diagnostics Business Overview
7.14.3 Vela Diagnostics Genomic and Proteomic Tool Major Product Offerings
7.14.4 Vela Diagnostics Genomic and Proteomic Tool Revenue in Global Market (2018-2023)
7.14.5 Vela Diagnostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Genomic and Proteomic Tool Market Opportunities & Trends in Global Market
Table 2. Genomic and Proteomic Tool Market Drivers in Global Market
Table 3. Genomic and Proteomic Tool Market Restraints in Global Market
Table 4. Key Players of Genomic and Proteomic Tool in Global Market
Table 5. Top Genomic and Proteomic Tool Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Genomic and Proteomic Tool Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Genomic and Proteomic Tool Revenue Share by Companies, 2018-2023
Table 8. Global Companies Genomic and Proteomic Tool Product Type
Table 9. List of Global Tier 1 Genomic and Proteomic Tool Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genomic and Proteomic Tool Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Genomic and Proteomic Tool Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Genomic and Proteomic Tool Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Genomic and Proteomic Tool Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Genomic and Proteomic Tool Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Genomic and Proteomic Tool Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Genomic and Proteomic Tool Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Genomic and Proteomic Tool Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Genomic and Proteomic Tool Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Genomic and Proteomic Tool Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Genomic and Proteomic Tool Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Genomic and Proteomic Tool Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Genomic and Proteomic Tool Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Genomic and Proteomic Tool Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Genomic and Proteomic Tool Revenue, (US$, Mn), 2024-2029
Table 30. 3billion, Inc. Company Summary
Table 31. 3billion, Inc. Genomic and Proteomic Tool Product Offerings
Table 32. 3billion, Inc. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 33. 3billion, Inc. Key News & Latest Developments
Table 34. Bio-Rad Laboratories, Inc. Company Summary
Table 35. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Product Offerings
Table 36. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 37. Bio-Rad Laboratories, Inc. Key News & Latest Developments
Table 38. Lucigen Corp. Company Summary
Table 39. Lucigen Corp. Genomic and Proteomic Tool Product Offerings
Table 40. Lucigen Corp. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 41. Lucigen Corp. Key News & Latest Developments
Table 42. Macrogen, Inc. Company Summary
Table 43. Macrogen, Inc. Genomic and Proteomic Tool Product Offerings
Table 44. Macrogen, Inc. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 45. Macrogen, Inc. Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Genomic and Proteomic Tool Product Offerings
Table 48. Abbott Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. Thermal Fisher Scientific, Inc. Company Summary
Table 51. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Product Offerings
Table 52. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 53. Thermal Fisher Scientific, Inc. Key News & Latest Developments
Table 54. Bio-Synthesis, Inc. Company Summary
Table 55. Bio-Synthesis, Inc. Genomic and Proteomic Tool Product Offerings
Table 56. Bio-Synthesis, Inc. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 57. Bio-Synthesis, Inc. Key News & Latest Developments
Table 58. GE Healthcare Company Summary
Table 59. GE Healthcare Genomic and Proteomic Tool Product Offerings
Table 60. GE Healthcare Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 61. GE Healthcare Key News & Latest Developments
Table 62. QIAGEN NV Company Summary
Table 63. QIAGEN NV Genomic and Proteomic Tool Product Offerings
Table 64. QIAGEN NV Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 65. QIAGEN NV Key News & Latest Developments
Table 66. Novogene Corp. Company Summary
Table 67. Novogene Corp. Genomic and Proteomic Tool Product Offerings
Table 68. Novogene Corp. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 69. Novogene Corp. Key News & Latest Developments
Table 70. Waters Corp. Company Summary
Table 71. Waters Corp. Genomic and Proteomic Tool Product Offerings
Table 72. Waters Corp. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 73. Waters Corp. Key News & Latest Developments
Table 74. OriGene Technologies Company Summary
Table 75. OriGene Technologies Genomic and Proteomic Tool Product Offerings
Table 76. OriGene Technologies Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 77. OriGene Technologies Key News & Latest Developments
Table 78. Takara Bio, Inc. Company Summary
Table 79. Takara Bio, Inc. Genomic and Proteomic Tool Product Offerings
Table 80. Takara Bio, Inc. Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 81. Takara Bio, Inc. Key News & Latest Developments
Table 82. Vela Diagnostics Company Summary
Table 83. Vela Diagnostics Genomic and Proteomic Tool Product Offerings
Table 84. Vela Diagnostics Genomic and Proteomic Tool Revenue (US$, Mn) & (2018-2023)
Table 85. Vela Diagnostics Key News & Latest Developments
List of Figures
Figure 1. Genomic and Proteomic Tool Segment by Type in 2022
Figure 2. Genomic and Proteomic Tool Segment by Application in 2022
Figure 3. Global Genomic and Proteomic Tool Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genomic and Proteomic Tool Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Genomic and Proteomic Tool Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genomic and Proteomic Tool Revenue in 2022
Figure 8. By Type - Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 9. By Application - Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 10. By Type - Global Genomic and Proteomic Tool Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 12. By Application - Global Genomic and Proteomic Tool Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 14. By Region - Global Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 15. By Country - North America Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 16. US Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 20. Germany Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 21. France Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 28. China Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 32. India Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 34. Brazil Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Genomic and Proteomic Tool Revenue Market Share, 2018-2029
Figure 37. Turkey Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Genomic and Proteomic Tool Revenue, (US$, Mn), 2018-2029
Figure 41. 3billion, Inc. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Lucigen Corp. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Macrogen, Inc. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bio-Synthesis, Inc. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GE Healthcare Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. QIAGEN NV Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novogene Corp. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Waters Corp. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. OriGene Technologies Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Takara Bio, Inc. Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Vela Diagnostics Genomic and Proteomic Tool Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
